fashion -WSS

fashion

author：entertainment 2025-09-30 22:10:46 - browse：7

A person reaching for a bottle of lipitor. -- first opinion coverage from STAT — John Moore/Getty Images

The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A world where an accidental scratch in the rose garden can kill.

Why is the supply of new antibiotics so thin, and growing thinner? A high-profile Wall Street Journal article recently highlighted what everyone knows: There is huge need but no market demand.

There are many interrelated causes. Doctors prefer to keep novel antibiotics in reserve, as a last-resort option, limiting sales volumes. Insurance companies like novel antibiotics that prevent costly ICU stays, but they’re used to the cheap price of older generics and balk at any price that allows recoupment of the full cost of development. Low prices and small volumes are a great recipe for insolvency as Achaogen’s experience showed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Second House panel advances two

WSS

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Wearables generate powerful data but its not useful to doctors, yet

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Venture capitalist Bob Kocher on the state of digital health

hotspot

fashion

knowledge

Sports medicine is finally prioritizing gender equality

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Hepatitis C has a cure — but many Americans still lack access to it

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Medical leaders decry Supreme Court decision on affirmative action

With measles on the rise, a personal story of a devastating disease

FDA approval of Sarepta Duchenne genetic therapy gives me hope

China dismisses criticism of top diplomat's comments appearing to push for race

Alkermes shareholders re

HIV vaccine remains elusive. Immunologists keep trying new ideas

focus

Case highlights the risks of experimental stem cell therapy

Condition critical? Britain's beloved but battered National Health Service turns 75

China dismisses criticism of top diplomat's comments appearing to push for race

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

NVIDIA and Google execs on the future of AI and drug discovery

focus

focus

focus

entertainment